| Financial Year |
March 31 2023 |
| Monetary Funds |
7,686,093,680.78 |
| Held-for-trading Financial Assets |
10,382,542,228.72 |
| Notes Receivable |
167,876,807.81 |
| Accounts Receivable |
2,268,392,200.76 |
| Advances to Suppliers |
439,654,521.65 |
| Other Receivables |
126,344,841.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
7,507,062.51 |
| Inventories |
2,952,217,247.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,797,518.04 |
| Other Current Assets |
402,208,585.12 |
| Total Current Assets |
24,440,118,816.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
72,057,678.75 |
| Long-term Equity Investment |
6,251,527,828.92 |
| Investment Properties |
160,358,214.41 |
| Fixed Assetes |
6,844,742,142.31 |
| Under-construction Projects |
406,832,250.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,241,697,191.87 |
| R&D expenses |
-- |
| Goodwill |
600,585,712.42 |
| Long-Term Deferred and Prepaid Expenses |
34,340,525.42 |
| Deferred Income Tax Assets |
660,178,961.45 |
| Other Non-Current Assets |
100,000,000.00 |
| Sub-Total of Non-Current Assets |
19,686,537,219.80 |
| Total Assets |
44,126,656,036.01 |
| Short-Term Loans |
1,300,782,361.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,974,314.08 |
| Accounts Payable |
2,858,802,993.69 |
| Accounts Received In Advance |
50,476,463.14 |
| Employee Compensation Payable |
284,631,809.55 |
| Taxes Payable |
152,303,064.63 |
| Interest Payable |
-- |
| Dividend Payable |
23,418,773.46 |
| Other payables |
715,737,554.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
269,815,891.28 |
| Other Current Liabilities |
166,388,015.63 |
| Sub-Total of Current Liabilities |
7,595,408,472.49 |
| Long-term Loans |
709,617,835.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
37,634,990.55 |
| Deferred Income Tax Liabilities |
346,539,598.06 |
| Other Non-Current Liabilities |
4,279,520.82 |
| Sub-Total of Non-Current Liabilities |
1,617,580,818.68 |
| Total Liabilities |
9,212,989,291.17 |
| Paid-In Capital(Or Share Stock) |
3,414,500,201.00 |
| Capital Surplus |
11,060,260,280.09 |
| Surplus Reserve |
2,153,004,462.47 |
| LESS:Treasury Stock |
500,000,157.78 |
| Undistributed Profits |
13,811,459,716.69 |
| Minority Stockholder's Interest |
5,211,588,892.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
29,702,077,852.23 |
| Owner's Equity（Stockholder's Equity） |
34,913,666,744.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
44,126,656,036.01 |
